Related references
Note: Only part of the references are listed.Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes
Rhiannon B. Werder et al.
MOLECULAR THERAPY (2021)
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq
Mitchell G. Kluesner et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Systematic comparison of somatic variant calling performance among different sequencing depth and mutation frequency
Zixi Chen et al.
SCIENTIFIC REPORTS (2020)
Alpha1-Antitrypsin Deficiency
Pavel Strnad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides
Tobias Merkle et al.
NATURE BIOTECHNOLOGY (2019)
In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
Dhruva Katrekar et al.
NATURE METHODS (2019)
RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing
Genghao Chen et al.
BIOCHEMISTRY (2019)
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
Liang Qu et al.
NATURE BIOTECHNOLOGY (2019)
A New Antisense Phosphoryl Guanidine Oligo-2′-O-Methylribonucleotide Penetrates Into Intracellular Mycobacteria and Suppresses Target Gene Expression
Yulia Skvortsova et al.
FRONTIERS IN PHARMACOLOGY (2019)
Abundant off-target edits from site-directed RNA editing can be reduced by nuclear localization of the editing enzyme
Isabel C. Vallecillo-Viejo et al.
RNA BIOLOGY (2018)
Why dystrophin quantification is key in the eteplirsen saga
Annemieke Aartsma-Rus et al.
NATURE REVIEWS NEUROLOGY (2018)
The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies
Maja M. Janas et al.
TOXICOLOGIC PATHOLOGY (2018)
Comparing the performance of selected variant callers using synthetic data and genome segmentation
Xiaopeng Bian et al.
BMC BIOINFORMATICS (2018)
EditR: A Method to Quantify Base Editing from Sanger Sequencing
Mitchell G. Kluesner et al.
CRISPR JOURNAL (2018)
Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
Naoki Iwamoto et al.
NATURE BIOTECHNOLOGY (2017)
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates
Jayaprakash K. Nair et al.
NUCLEIC ACIDS RESEARCH (2017)
Site-directed RNA repair of endogenous Mecp2 RNA in neurons
John R. Sinnamon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
RNA editing with CRISPR-Cas13
David B. T. Cox et al.
SCIENCE (2017)
Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing
Masatora Fukuda et al.
Scientific Reports (2017)
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney et al.
LANCET (2016)
Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
Klaudia Kawecka et al.
CURRENT GENE THERAPY (2015)
Dose-Response Analysis Using R
Christian Ritz et al.
PLOS ONE (2015)
Improving Site-Directed RNA Editing In Vitro and in Cell Culture by Chemical Modification of the GuideRNA
Paul Vogel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans
Marius F. Schneider et al.
NUCLEIC ACIDS RESEARCH (2014)
A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications
Peter Jaerver et al.
NUCLEIC ACID THERAPEUTICS (2014)
Phosphoryl Guanidines: A New Type of Nucleic Acid Analogues
M. S. Kupryushkin et al.
ACTA NATURAE (2014)
Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing
Maria Fernanda Montiel-Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Simultaneous inference in general parametric models
Torsten Hothorn et al.
BIOMETRICAL JOURNAL (2008)
Uracil in DNA - occurrence, consequences and repair
HE Krokan et al.
ONCOGENE (2002)
Substrate recognition by ADAR1 and ADAR2
SK Wong et al.
RNA (2001)
Share Paper
